Vanessa Smith

Active 1978–2025

183
Papers
19,579
Citations
66
h-index
169
i10-index

Citations

Citations per year for Vanessa Smith1978: 6 citations1982: 1 citations1990: 3 citations1991: 7 citations1992: 2 citations1993: 1 citations1994: 4 citations1995: 5 citations1996: 6 citations1997: 7 citations1998: 8 citations1999: 8 citations2000: 7 citations2001: 6 citations2002: 6 citations2003: 10 citations2004: 13 citations2005: 11 citations2006: 21 citations2007: 16 citations2008: 27 citations2009: 29 citations2010: 45 citations2011: 50 citations2012: 64 citations2013: 81 citations2014: 81 citations2015: 92 citations2016: 86 citations2017: 103 citations2018: 104 citations2019: 547 citations2020: 665 citations2021: 767 citations2022: 822 citations2023: 568 citations2024: 997 citations2025: 501 citations2026: 11 citations1979–1981: no citations, so these years are not shown1983–1989: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,353 citing papers, 18.1% of this breakdownItaly: 668 citing papers, 8.9% of this breakdownChina: 596 citing papers, 8% of this breakdownUnited Kingdom: 590 citing papers, 7.9% of this breakdownGermany: 424 citing papers, 5.7% of this breakdownFrance: 396 citing papers, 5.3% of this breakdownNetherlands: 296 citing papers, 4% of this breakdownCanada: 259 citing papers, 3.5% of this breakdownSpain: 231 citing papers, 3.1% of this breakdownSwitzerland: 215 citing papers, 2.9% of this breakdownJapan: 204 citing papers, 2.7% of this breakdownBelgium: 202 citing papers, 2.7% of this breakdown
0%18.1%Other 27.2%

Fields

  • Medicine75.8%
  • Biochemistry, Genetics and Molecular Biology7.8%
  • Immunology and Microbiology4.1%
  • Psychology2.5%
  • Neuroscience2.4%
  • Social Sciences2.3%
  • Other5.1%

Topics

  • Systemic Sclerosis and Related Diseases13.1%
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis5.6%
  • Inflammatory Myopathies and Dermatomyositis4.9%
  • Dementia and Cognitive Impairment Research4.4%
  • Systemic Lupus Erythematosus Research2%
  • Dermatologic Treatments and Research1.9%
  • Other68.1%

Coauthors

All papers

Open in search
  1. Systemic sclerosis

    Authors: , , - The Lancet 2022 cited by 552

  2. Macrophage M1/M2 polarization and rheumatoid arthritis: A systematic review

    Authors: , , , , , , , , - Autoimmunity Reviews 2019 cited by 441

  3. Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mette Mogensen, Anne Braae Olesen, Yannick Allanore, J. Henes, Ulf Müller‐Ladner, Gabriela Riemekasten, Alla Skapenko, Panayiotis G. Vlachoyiannopoulos, Emese Kiss, Tünde Minier, Lorenzo Beretta, Elisa Gremese, Marco Matucci‐Cerinic, Gabriele Valentini, Yoshihide Asano, Tatsuya Atsumi, Hironobu Ihn, Tomonori Ishii, Osamu Ishikawa, Masataka Kuwana, Yoshihito Shima, Hiroki Takahashi, Kazuhiko Takehara, Yoshiya Tanaka, Yoshioki Yamasaki, Loreta Bukauskienė, İrena Butrimienė, Gabriel Medrano Ramírez, César Ramos-Remus, Tatiana Sofía Rodríguez Reyna, Jeska de Vries‐Bouwstra, Jacob M. van Laar, Bogdan Batko, Sławomir Jeka, Eugeniusz J. Kucharz, Maria Majdan, Marzena Olesińska, Żaneta Smoleńska, José Delgado Alves, María José Santos, C. Mihai, Simona Rednic, Ivan Castellvi Barranco, Francisco Longo, C Simeόn Aznar, Patrícia Carreira, Oliver Distler, Ulrich A. Walker, Emma Derrett‐Smith, Bridget Griffiths, Neil D McKay, Christopher P. Denton, Jacob Aelion, Michael Borofsky, Roy Fleischmann, Joseph Z. Forstot, Daniel E. Furst, Suzanne Kafaja, Mahmuda Khan, Dinesh Khanna, Michael Kohen, Richard W. Martin, Fabian Mendoza-Ballesteros, Alireza Nami, Shirley Pang, Grissel Ríos, Robert W. Simms, Keith M. Sullivan, Virginia Steen - The Lancet Respiratory Medicine 2020 cited by 652

  4. Validation of the NPI-Q, a Brief Clinical Form of the Neuropsychiatric Inventory

    Authors: , , , , , , , - Journal of Neuropsychiatry 2000 cited by 1,947

  5. Mapping and predicting mortality from systemic sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Vanessa Smith, Carolina de Souza Müller, Carlomaurizio Montecucco, Daniela Opriș-Belinski, Francesca Ingegnoli, Panayiotis G. Vlachoyiannopoulos, Bojana Stamenković, Edoardo Rosato, Stefan Heitmann, Jörg H. W. Distler, Thierry Zénone, Matthias Seidel, Alessandra Vacca, Ellen De Langhe, Srđan Novak, Maurizio Cutolo, Luc Mouthon, Jörg Henes, Carlo Chizzolini, Carlos Alberto von Mühlen, Kamal Solanki, Simona Rednic, Lisa K. Stamp, Branimir Anić, Vera Ortiz-Santamaría, Maria De Santis, Şule Yavuz, Walter Alberto Sifuentes Giraldo, Emmanuel Chatelus, Jiří Štork, Jacob M. van Laar, Esthela Loyo, Paloma García de la Peña Lefebvre, Kilian Eyerich, Vanesa Cosentino, Juan José Alegre Sancho, Otylia Kowal‐Bielecka, Grégoire Rey, Marco Matucci‐Cerinic, Yannick Allanore - Annals of the Rheumatic Diseases 2017 cited by 684

  6. Update of EULAR recommendations for the treatment of systemic sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alan Tyndall, Joep Welling, F Wigley, Gabriele Valentini, Ulrich A. Walker, Francesco Zulian, Ulf Müller‐Ladner, Thomas Daikeler, Elisabetta Lanciano, Radim Bečvář, Michal Tomcik, Ewa Gińdzieńska-Sieśkiewicz, Giovanna Cuomo, Michele Iudici, Simona Rednic, Panayiotis G. Vlachoyiannopoulos, Roberto Caporali, Patricia E. Carreira, Servicio de Reumatología, Srdan Novak, Tünde Minier, Eugene J. Kucharz, Armando Gabrielli, Gianluca Moroncini, Paolo Airo', Roger Hesselstrand, Duska Martinovic, Mislav Radić, Daniela Marasovic-Krstulovic, Yolanda Braun-Moscovici, Alexandra Balbir-Gurman, Andrea Lo Monaco, Paola Caramaschi, Jadranka Morović-Vergles, Melanie I. Čulo, Jörg Henes, Vera Ortiz Santamaria, Stefan Heitmann, Dorota Krasowska, Małgorzata Michalska-Jakubus, Matthias F. Seidel, Paul Hasler, Klinik für Rheumatologie, José A. Pereira Da Silva, Maria J. Salvador, Bojana Stamenkovic, Aleksandra Stankovic, Mohammed Tikly, Lidia P. Ananieva, Lorenzo Beretta, Gabriella Szucs, Szilvia Szamosi, Carlos de la Puente Bujidos, Servicio de Reumatología, Øyvind Midtvedt, Anna-Maria Hoffmann-Vold, David Launay, Eric Hachulla, Valeria Riccieri, Ruxandra Ionescu, Daniela Opris, Carina Mihai, Ilka Herrgott, Christian Beyer, Francesca Ingegnoli, Carlos Alberto von Mühlen, Juan José Alegre-Sancho, Emma Beltrán-Catalán, Martin Aringer, Julia Fantana and 35 more - Annals of the Rheumatic Diseases 2016 cited by 1,116

  7. Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Autoimmunity Reviews 2020 cited by 500

  8. Pathophysiology of systemic sclerosis: current understanding and new insights

    Authors: , , - Expert Review of Clinical Immunology 2019 cited by 361

  9. Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Leo A. B. Joosten, Vanessa Smith, Filip De Keyser, Rafaella Scorza, C. Lunardi, Piet L. C. M. van Riel, Madelon C Vonk, Waander L. van Heerde, Stephan Meller, Bernhard Homey, Lorenzo Beretta, Mark Roest, Maria Trojanowska, Robert Lafyatis, Timothy R. D. J. Radstake - New England Journal of Medicine 2013 cited by 454

  10. Stereotype content model across cultures: Towards universal similarities and some differences

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - British Journal of Social Psychology 2009 cited by 1,046

  11. Predictors of progression in systemic sclerosis patients with interstitial lung disease

    Authors: , , , , , , , , , , , , - European Respiratory Journal 2020 cited by 239

  12. A circulating cell population showing both M1 and M2 monocyte/macrophage surface markers characterizes systemic sclerosis patients with lung involvement

    Authors: , , , , , , , , , , , - Respiratory Research 2018 cited by 212

  13. Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gabriela Riemekasten, Simona Rednic, Edoardo Rosato, Marta Saracco, A Scheja, Vanessa Smith, Carina Mihai, Gabriela Szucs, Matija Tomšič, Gabriele Valentini, Ulrich A. Walker, R Westhovens, Şule Yavuz, Thierry Zénone - Annals of the Rheumatic Diseases 2014 cited by 428

  14. Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group

    Authors: , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2010 cited by 438

  15. Progression of patients with Raynaud's phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma Trial and Research group multicentre, longitudinal registry study for Very Early Diagnosis of Systemic Sclerosis (VEDOSS)

    Authors: , , , , , , , , , , , , , , - The Lancet Rheumatology 2021 cited by 143

  16. Nailfold capillaroscopy

    Authors: , , , , , , - Best Practice & Research Clinical Rheumatology 2023 cited by 102

  17. Epidemiology of interstitial lung diseases and their progressive-fibrosing behaviour in six European countries

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ilias Dimeas, Theodora Simopoulou, Evangelia Fouka, Ioanna Tsiouprou, Athanasios Zaharias, Sérgio Campainha, Carla Nogueira, Sara Freitas, Vânia Fernandes, Carolina Cabo, Eirini Vasarmidi - ERJ Open Research 2021 cited by 77

  18. Fast track algorithm: How to differentiate a “scleroderma pattern” from a “non-scleroderma pattern”

    Authors: , , , , , , , , , , , , , , , , , , - Autoimmunity Reviews 2019 cited by 169

  19. Increase in circulating cells coexpressing M1 and M2 macrophage surface markers in patients with systemic sclerosis

    Authors: , , , , , , , , , , , - Annals of the Rheumatic Diseases 2018 cited by 120

  20. Detection of microvascular changes in systemic sclerosis and other rheumatic diseases

    Authors: , - Nature Reviews Rheumatology 2021 cited by 112

  21. CTLA4-Ig treatment induces M1–M2 shift in cultured monocyte-derived macrophages from healthy subjects and rheumatoid arthritis patients

    Authors: , , , , , , , , , - Arthritis Research & Therapy 2021 cited by 43

  22. Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2020 cited by 107

  23. Involvement of the secosteroid vitamin D in autoimmune rheumatic diseases and COVID-19

    Authors: , , , - Nature Reviews Rheumatology 2023 cited by 51

  24. A deep learning system for quantitative assessment of microvascular abnormalities in nailfold capillary images

    Authors: , , , , , , , , , - Lara D. Veeken 2023 cited by 37